Despite the Wegovy FDA approval, individuals must understand that side effects and Wegovy pen malfunction s may still occur
References: A Brave New World: Therapeutic Area Deep Dives on Obesity This blog is part of a new series exploring a range of topics in the obesity market, including: market size and scope, impact of payer controls, activity in non-traditional channels, patient behavior, GLP-1 impact, HCP responses, the policy landscape, pharmacy economics, and the outlook for the future of GLP-1
Its important to keep in mind that using insulin alongside Ozempic increases your risk of side effects and hypoglycemia (low blood sugar)
Research shows that people who have MS and a BMI score in the overweight or obese range tend to report worse disability
The STEP 1 clinical trial showed Wegovy leads to an average weight loss of around 15% after 68 weeks, making it one of the most effective weight-loss medications available